61 drugs reach their earliest generic-entry date in 2030

Jan 2030 · 3

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Salonpas · 2 strengths menthol; methyl salicylate	menthol; methyl salicylate	Hisamitsu Pharm Co	022029	3 Jan 2030	patent
Omeprazole omeprazole	omeprazole	Dexcel Pharma	022032	31 Jan 2030	patent
Revatio sildenafil citrate	sildenafil citrate	Viatris	021845	31 Jan 2030	exclusivity

Feb 2030 · 4

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Kalydeco ivacaftor	ivacaftor	Vertex Pharms	203188	13 Feb 2030	patent
Flolipid · 2 strengths simvastatin	simvastatin	Salerno Pharms	206679	23 Feb 2030	patent
Fabior tazarotene	tazarotene	Mayne Pharma	202428	24 Feb 2030	patent
Quzyttir cetirizine hydrochloride	cetirizine hydrochloride	Esteve	211415	28 Feb 2030	patent, carve-out possible

Mar 2030 · 10

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Myoview 30ml technetium tc-99m tetrofosmin kit	technetium tc-99m tetrofosmin kit	Medi-Physics	020372	10 Mar 2030	patent
Vraylar · 6 strengths cariprazine hydrochloride	cariprazine hydrochloride	Abbvie	204370	17 Mar 2030	patent
Tepmetko tepotinib hydrochloride	tepotinib hydrochloride	Emd Serono Inc	214096	19 Mar 2030	patent
Joenja · 2 strengths leniolisib phosphate	leniolisib phosphate	Pharming	217759	24 Mar 2030	exclusivity
Otovel ciprofloxacin hydrochloride; fluocinolone acetonide	ciprofloxacin hydrochloride; fluocinolone acetonide	Lab Salvat	208251	24 Mar 2030	patent
Vonjo pacritinib citrate	pacritinib citrate	Sobi	208712	25 Mar 2030	patent
Qutenza capsaicin	capsaicin	Averitas	022395	26 Mar 2030	patent
Suboxone · 4 strengths buprenorphine hydrochloride; naloxone hydrochloride	buprenorphine hydrochloride; naloxone hydrochloride	Indivior	022410	26 Mar 2030	patent
Myrbetriq · 2 strengths mirabegron	mirabegron	Apgdi	202611	28 Mar 2030	patent
Oxycontin · 4 strengths oxycodone hydrochloride	oxycodone hydrochloride	Knoa Pharma	022272	29 Mar 2030	patent

Apr 2030 · 5

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Kovanaze oxymetazoline hydrochloride; tetracaine hydrochloride	oxymetazoline hydrochloride; tetracaine hydrochloride	St Renatus	208032	2 Apr 2030	patent
Jynarque · 5 strengths tolvaptan	tolvaptan	Otsuka	204441	7 Apr 2030	patent
Samsca · 2 strengths tolvaptan	tolvaptan	Otsuka	022275	7 Apr 2030	patent
Briviact · 5 strengths brivaracetam	brivaracetam	Ucb Inc	205836	9 Apr 2030	patent
Zyclara imiquimod	imiquimod	Bausch	022483	30 Apr 2030	patent, carve-out possible

May 2030 · 3

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Apriso mesalamine	mesalamine	Salix	022301	1 May 2030	patent, carve-out possible
Airsupra albuterol sulfate; budesonide	albuterol sulfate; budesonide	Astrazeneca	214070	28 May 2030	patent, carve-out possible
Symbicort Aerosphere · 2 strengths budesonide; formoterol fumarate	budesonide; formoterol fumarate	Astrazeneca	216579	28 May 2030	patent

Jun 2030 · 8

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Isentress raltegravir potassium	raltegravir potassium	Msd Sub Merck	203045	2 Jun 2030	patent
Isentress raltegravir potassium	raltegravir potassium	Msd Sub Merck	022145	2 Jun 2030	patent
Onureg · 2 strengths azacitidine	azacitidine	Bristol	214120	3 Jun 2030	patent
Tivicay dolutegravir sodium	dolutegravir sodium	Viiv Hlthcare	204790	8 Jun 2030	patent
Tivicay Pd dolutegravir sodium	dolutegravir sodium	Viiv Hlthcare	213983	8 Jun 2030	patent
Triumeq abacavir sulfate; dolutegravir sodium; lamivudine	abacavir sulfate; dolutegravir sodium; lamivudine	Viiv Hlthcare	205551	8 Jun 2030	patent
Triumeq Pd abacavir sulfate; dolutegravir sodium; lamivudine	abacavir sulfate; dolutegravir sodium; lamivudine	Viiv Hlthcare	215413	8 Jun 2030	patent
Ella ulipristal acetate	ulipristal acetate	Lab Hra Pharma	022474	12 Jun 2030	patent, carve-out possible

Jul 2030 · 9

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Minivelle · 5 strengths estradiol	estradiol	Noven	203752	4 Jul 2030	patent
Invokamet · 4 strengths canagliflozin; metformin hydrochloride	canagliflozin; metformin hydrochloride	Janssen Pharms	204353	6 Jul 2030	patent
Lumify brimonidine tartrate	brimonidine tartrate	Bausch And Lomb Inc	208144	14 Jul 2030	patent, carve-out possible
Lumify Preservative Free brimonidine tartrate	brimonidine tartrate	Bausch And Lomb Inc	218424	14 Jul 2030	patent, carve-out possible
Beyaz drospirenone; ethinyl estradiol; levomefolate calcium	drospirenone; ethinyl estradiol; levomefolate calcium	Bayer Hlthcare	022532	17 Jul 2030	patent
Safyral drospirenone; ethinyl estradiol; levomefolate calcium	drospirenone; ethinyl estradiol; levomefolate calcium	Bayer Hlthcare	022574	17 Jul 2030	patent
Eucrisa crisaborole	crisaborole	Anacor Pharms Inc	207695	20 Jul 2030	patent
Auryxia ferric citrate	ferric citrate	Keryx Biopharms	205874	21 Jul 2030	patent
Nexplanon etonogestrel	etonogestrel	Organon	021529	28 Jul 2030	patent

Aug 2030 · 1

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Children's Allegra Allergy fexofenadine hydrochloride	fexofenadine hydrochloride	Chattem Sanofi	201373	2 Aug 2030	patent

Sep 2030 · 3

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Exxua · 4 strengths gepirone hydrochloride	gepirone hydrochloride	Fabre Kramer	021164	2 Sep 2030	patent, carve-out possible
Silenor · 2 strengths doxepin hydrochloride	doxepin hydrochloride	Currax	022036	7 Sep 2030	patent, carve-out possible
Ravicti glycerol phenylbutyrate	glycerol phenylbutyrate	Horizon Therap Us	203284	22 Sep 2030	patent, carve-out possible

Oct 2030 · 5

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Zilxi minocycline hydrochloride	minocycline hydrochloride	Journey	213690	1 Oct 2030	patent
Inpefa · 2 strengths sotagliflozin	sotagliflozin	Lexicon Pharms Inc	216203	7 Oct 2030	patent
Tygacil tigecycline	tigecycline	Pf Prism Cv	021821	8 Oct 2030	patent
Rozlytrek entrectinib	entrectinib	Genentech Inc	218550	20 Oct 2030	exclusivity
Simbrinza brimonidine tartrate; brinzolamide	brimonidine tartrate; brinzolamide	Alcon Labs Inc	204251	30 Oct 2030	patent

Nov 2030 · 4

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Tobi Podhaler tobramycin	tobramycin	Viatris	201688	4 Nov 2030	patent
Amondys 45 casimersen	casimersen	Sarepta Theraps Inc	213026	12 Nov 2030	patent
Farxiga dapagliflozin	dapagliflozin	Astrazeneca Ab	202293	26 Nov 2030	patent
Anoro Ellipta umeclidinium bromide; vilanterol trifenatate	umeclidinium bromide; vilanterol trifenatate	Glaxosmithkline	203975	29 Nov 2030	patent

Dec 2030 · 6

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Fosrenol · 2 strengths lanthanum carbonate	lanthanum carbonate	Takeda Pharms Usa	204734	1 Dec 2030	patent
Rydapt midostaurin	midostaurin	Novartis	207997	2 Dec 2030	patent, carve-out possible
Spinraza · 2 strengths nusinersen sodium	nusinersen sodium	Biogen	209531	23 Dec 2030	patent
Relistor · 3 strengths methylnaltrexone bromide	methylnaltrexone bromide	Salix Pharms	021964	31 Dec 2030	patent, carve-out possible
Sivextro tedizolid phosphate	tedizolid phosphate	Cubist Pharms Llc	205435	31 Dec 2030	patent
Sivextro tedizolid phosphate	tedizolid phosphate	Cubist Pharms Llc	205436	31 Dec 2030	patent